RA Capital Management

Ra Capital Management as of Sept. 30, 2016

Portfolio Holdings for Ra Capital Management

Ra Capital Management holds 30 positions in its portfolio as reported in the September 2016 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Wave Life Sciences (WVE) 23.4 $230M 7.1M 32.47
Achillion Pharmaceuticals 9.9 $98M 12M 8.10
Ascendis Pharma A S (ASND) 7.5 $74M 3.7M 20.10
Avexis 7.3 $71M 1.7M 41.21
Axovant Sciences 7.1 $70M 5.0M 14.00
Nektar Therapeutics (NKTR) 6.4 $63M 3.7M 17.18
Zogenix 4.5 $45M 2.7M 16.75
Ardelyx (ARDX) 4.3 $42M 3.3M 12.94
Aclaris Therapeutics (ACRS) 4.0 $40M 1.5M 25.61
Tg Therapeutics (TGTX) 3.6 $36M 4.6M 7.74
Aquinox Pharmaceuticals 3.0 $29M 2.2M 13.36
Aimmune Therapeutics 2.0 $19M 1.3M 15.00
Foamix Pharmaceuticals 1.7 $17M 1.8M 9.26
Protagonist Therapeutics (PTGX) 1.6 $16M 754k 21.13
Proteon Therapeutics 1.6 $15M 1.6M 9.33
Dicerna Pharmaceuticals 1.4 $14M 2.4M 5.88
BioCryst Pharmaceuticals (BCRX) 1.3 $13M 3.0M 4.41
Strongbridge Bioph shs usd 1.3 $13M 2.5M 5.22
Audentes Therapeutics 1.3 $13M 707k 17.81
Dimension Therapeutics 1.3 $12M 1.5M 7.99
Acceleron Pharma 1.2 $12M 319k 36.19
Arrowhead Pharmaceuticals (ARWR) 1.1 $11M 1.5M 7.35
Tenax Therapeutics 0.6 $5.5M 2.4M 2.31
Beigene (BGNE) 0.5 $5.2M 170k 30.81
Alcobra 0.5 $5.1M 2.0M 2.47
Eiger Biopharmaceuticals (EIGR) 0.5 $4.7M 354k 13.39
Sangamo Biosciences (SGMO) 0.4 $4.2M 899k 4.63
Aeglea Biotherapeutics 0.2 $2.2M 336k 6.41
Arca Biopharma 0.1 $1.5M 522k 2.83
Akari Therapeutics 0.1 $971k 114k 8.51